Richard Cathomas
RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?
Cathomas R, Rothermundt C, Bode B, Fuchs B, von Moos R, Schwitter M. RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?. Oncology 2014; 88:257-260.
17.12.2014RANK Ligand Blockade with Denosumab in Combination with Sorafenib in Chemorefractory Osteosarcoma: A Possible Step Forward?
17.12.2014Oncology 2014; 88:257-260
Cathomas Richard, Rothermundt Christian, Bode Beata, Fuchs Bruno, von Moos Roger, Schwitter Michael
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Sebastian M, Gnad-Vogt U, Kallen K, Heidenreich R, Fotin-Mleczek M, Scheel B, Koch S, Rippin G, Wehler T, Hilbe W, Cathomas R, Früh M, Weiss C, Papachristofilou A, Zippelius A. Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer. BMC cancer 2014; 14:748.
06.10.2014Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
06.10.2014BMC cancer 2014; 14:748
Sebastian Martin, Gnad-Vogt Ulrike, Kallen Karl-Josef, Heidenreich Regina, Fotin-Mleczek Mariola, Scheel Birgit, Koch Sven D, Rippin Gerd, Wehler Thomas, Hilbe Wolfgang, Cathomas Richard, Früh Martin, Weiss Christian, Papachristofilou Alexandros, Zippelius Alfred
Measurement or estimation of glomerular filtration rate in seminoma patients: Quite another cup of tea
Fehr M, Geldart T, Klingbiel D, Cathomas R. Measurement or estimation of glomerular filtration rate in seminoma patients: Quite another cup of tea. Eur J Cancer 2014; 50:2176-7.
07.06.2014Measurement or estimation of glomerular filtration rate in seminoma patients: Quite another cup of tea
07.06.2014Eur J Cancer 2014; 50:2176-7
Fehr Martin, Geldart Tom, Klingbiel Dirk, Cathomas Richard
Management of bone metastases in patients with castration-resistant prostate cancer
Cathomas R, Tantawy W, Pacik D, Milecki P, Kramer G, Kacso G, Goncalves F, Gillessen Sommer S, El Ghoneimy A, Bouzid M, Bajory Z, Lesniewski-Kmak K. Management of bone metastases in patients with castration-resistant prostate cancer. Urol Int 2014; 92:377-86.
30.04.2014Management of bone metastases in patients with castration-resistant prostate cancer
30.04.2014Urol Int 2014; 92:377-86
Cathomas Richard, Tantawy Wahid, Pacik Dalibor, Milecki Piotr, Kramer Gero, Kacso Gabriel, Goncalves Frederico, Gillessen Sommer Silke, El Ghoneimy Ahmed, Bouzid Mounira, Bajory Zoltan, Lesniewski-Kmak Krzystof
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
Rothermundt C, Cathomas R, Rüschoff J, Schiess R, Endt K, Lui L, Pollak M, Bärtschi D, Strebel R, Winterhalder R, Templeton A, Hayoz S, Gillessen Sommer S. Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). Eur Urol 2014; 66:468-74.
04.01.2014Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
04.01.2014Eur Urol 2014; 66:468-74
Rothermundt Christian, Cathomas Richard, Rüschoff Jan H, Schiess Ralph, Endt Kathrin, Lui Lillianne, Pollak Michael, Bärtschi Daniela, Strebel Räto T, Winterhalder Ralph, Templeton Arnoud, Hayoz Stefanie, Gillessen Sommer Silke
EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
Baty F, Brutsche M, Pless M, Zappa F, Crowe S, Bubendorf L, Gautschi O, Rauch D, Cathomas R, Dröge C, Betticher D, Früh M, Rothschild S, Swiss Group for Clinical Cancer Research. EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer. PloS one 2013; 8:e72966.
10.09.2013EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
10.09.2013PloS one 2013; 8:e72966
Baty Florent, Brutsche Martin, Pless Miklos, Zappa Francesco, Crowe Susanne, Bubendorf Lukas, Gautschi Oliver, Rauch Daniel, Cathomas Richard, Dröge Cornelia, Betticher Daniel, Früh Martin, Rothschild Sacha, Swiss Group for Clinical Cancer Research
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients
Clough-Gorr K, Noti L, Brauchli P, Cathomas R, Fried M, Roberts G, Stuck A, Hitz F, Mey U. The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients. BMC Med Inform Decis Mak 2013; 13:93.
23.08.2013The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients
23.08.2013BMC Med Inform Decis Mak 2013; 13:93
Clough-Gorr Kerri M, Noti Lea, Brauchli Peter, Cathomas Richard, Fried Marius R, Roberts Gillian, Stuck Andreas E, Hitz Felicitas, Mey Ulrich
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Templeton A, Schiess R, Wild P, Rüschoff J, Thalmann G, Dietrich P, Aebersold R, Klingbiel D, Gillessen Sommer S, Müller B, Winterhalder R, Stenner F, Dutoit V, Cathomas R, Rothermundt C, Bärtschi D, Dröge C, Gautschi O, Borner M, Fechter E, Swiss Group for Clinical Cancer Research (SAKK). Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08). Eur Urol 2013; 64:150-8.
06.04.2013Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
06.04.2013Eur Urol 2013; 64:150-8
Templeton Arnoud, Schiess Ralph, Wild Peter J, Rüschoff Jan H, Thalmann George, Dietrich Pierre-Yves, Aebersold Ruedi, Klingbiel Dirk, Gillessen Sommer Silke, Müller Beat, Winterhalder Ralph, Stenner Frank, Dutoit Valérie, Cathomas Richard, Rothermundt Christian, Bärtschi Daniela, Dröge Cornelia, Gautschi Oliver, Borner Markus, Fechter Eva, Swiss Group for Clinical Cancer Research (SAKK)
Multidisciplinary care in patients with prostate cancer: room for improvement
Strebel R, Winterhalder R, Morant R, Pless M, Huber U, Fehr M, Gillessen Sommer S, Schmid H, Sulser T, Cathomas R. Multidisciplinary care in patients with prostate cancer: room for improvement. Support Care Cancer 2013; 21:2327-33.
26.03.2013Multidisciplinary care in patients with prostate cancer: room for improvement
26.03.2013Support Care Cancer 2013; 21:2327-33
Strebel Räto T, Winterhalder Ralph, Morant Rudolf, Pless Miklos, Huber Urs, Fehr Martin, Gillessen Sommer Silke, Schmid Hans-Peter, Sulser Tullio, Cathomas Richard
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)
Cathomas R, Gillessen Sommer S, von Moos R, Schiess R, Pless M, Berthold D, Siciliano D, Winterhalder R, Droege C, Cotting D, Brauchli P, Betticher D, Jaggi R, Bubendorf L, Klingbiel D, Rothermundt C, Swiss Group for Clinical Cancer Research SAKK. Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07). Clin Cancer Res 2012; 18:6049-57.
12.09.2012Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)
12.09.2012Clin Cancer Res 2012; 18:6049-57
Cathomas Richard, Gillessen Sommer Silke, von Moos Roger, Schiess Ralph, Pless Miklos, Berthold Dominik R, Siciliano Daniele, Winterhalder Ralph, Droege Cornelia, Cotting Denise, Brauchli Peter, Betticher Daniel C, Jaggi Rolf, Bubendorf Lukas, Klingbiel Dirk, Rothermundt Christian, Swiss Group for Clinical Cancer Research SAKK
A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
Stenner F, Renner C, Porta C, Buchler T, Knuth A, Stoll S, Siciliano R, Rothermundt C, Cathomas R, Haile S, Liewen H, Chastonay R, Samaras P. A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma. Oncology 2012; 82:333-340.
02.06.2012A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma
02.06.2012Oncology 2012; 82:333-340
Stenner Frank, Renner Christoph, Porta Camillo, Buchler Tomas, Knuth Alexander, Stoll Susanna, Siciliano Raffaele D, Rothermundt Christian, Cathomas Richard, Haile Sarah R, Liewen Heike, Chastonay Rahel, Samaras Panagiotis
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)
Früh M, Pless M, Fustier P, Küttel E, Simcock M, Rauch D, Krasniqi F, Erdmann A, Mamot C, Zippelius A, Tscherry G, Siano M, Cathomas R, Swiss Group for Clinical Cancer Research. Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08). Clin Lung Cancer 2012; 14:34-9.
24.05.2012Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)
24.05.2012Clin Lung Cancer 2012; 14:34-9
Früh Martin, Pless Miklos, Fustier Pierre, Küttel Erika, Simcock Mathew, Rauch Daniel, Krasniqi Fatima, Erdmann Andreas, Mamot Christoph, Zippelius Alfred, Tscherry Gregor, Siano Marco, Cathomas Richard, Swiss Group for Clinical Cancer Research
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
Pesce G, Bernhard J, Kotrubczik N, D'Addario G, Pilop C, Weber D, Bodis S, Pless M, Mayer M, Cathomas R, Peters S, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar C, Fischer N, Anchisi S, Stupp R. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03). Eur J Cancer 2011; 48:377-84.
15.11.2011Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
15.11.2011Eur J Cancer 2011; 48:377-84
Pesce Gianfranco A, Bernhard Jürg, Kotrubczik Nina M, D'Addario Giannicola, Pilop Christiane, Weber Damien C, Bodis Stephan, Pless Miklos, Mayer Michael, Cathomas Richard, Peters Solange, Klingbiel Dirk, Ribi Karin, Zouhair Abderahim, von Moos Roger, Schlaeppi Marc, Caspar Clemens B, Fischer Natalie, Anchisi Sandro, Stupp Roger
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients
Souchon R, Hartmann M, Krege S, Lorch A, Mayer F, De Santis M, Gillessen Sommer S, Beyer J, Cathomas R. Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients. Strahlenther Onkol 2011; 187:158-66.
21.02.2011Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients
21.02.2011Strahlenther Onkol 2011; 187:158-66
Souchon Rainer, Hartmann Michael, Krege Susanne, Lorch Anja, Mayer Frank, De Santis Maria, Gillessen Sommer Silke, Beyer Jörg, Cathomas Richard
Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients
Cathomas R, Hartmann M, Krege S, Souchon R, Lorch A, Mayer F, De Santis M, Gillessen Sommer S, Interdisziplinäre Arbeitsgruppe Hodentumore. Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients. Onkologie 2011; 34:59-64.
17.01.2011Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients
17.01.2011Onkologie 2011; 34:59-64
Cathomas Richard, Hartmann Michael, Krege Susanne, Souchon Rainer, Lorch Anja, Mayer Frank, De Santis Maria, Gillessen Sommer Silke, Interdisziplinäre Arbeitsgruppe Hodentumore
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort
Cathomas R, De Santis M, Beyer J, Mayer F, Lorch A, Zaugg K, Seifert H, Shahin O, Rentsch C, Rothermundt C, Stenner F, Helbling D, Gillessen Sommer S. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkly 2010; 140:356-69.
26.06.2010Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort
26.06.2010Swiss Med Wkly 2010; 140:356-69
Cathomas Richard, De Santis Maria, Beyer Jörg, Mayer Frank, Lorch Anja, Zaugg Kathrin, Seifert Hans-Helge, Shahin Osama, Rentsch Cyrill, Rothermundt Christian, Stenner Frank, Helbling Daniel, Gillessen Sommer Silke
Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03)
von Moos R, Lanz D, Simcock M, Köberle D, Cathomas R, Uhlmann C, Widmer L, Ruhstaller T, Roth A, Popescu R. Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03). Onkologie 2010; 33:295-9.
01.01.2010Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03)
01.01.2010Onkologie 2010; 33:295-9
von Moos Roger, Lanz Doris, Simcock Mathew, Köberle Dieter, Cathomas Richard, Uhlmann Catrina, Widmer Lucas, Ruhstaller Thomas, Roth Arnaud, Popescu Razvan
Primary manifestation of small lymphocytic lymphoma in the prostate
Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen Sommer S, Cathomas R. Primary manifestation of small lymphocytic lymphoma in the prostate. Onkologie 2009; 32:586-8.
01.10.2009Primary manifestation of small lymphocytic lymphoma in the prostate
01.10.2009Onkologie 2009; 32:586-8
Fehr Martin, Templeton Arnoud, Cogliatti Sergio B., Aebersold Franziska, Egli Fritz, Gillessen Sommer Silke, Cathomas Richard
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Cathomas R, Köberle D, Ruhstaller T, Mayer G, Räss A, Mey U, von Moos R. Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009
12.09.2009Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
12.09.2009Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009
Cathomas Richard, Köberle Dieter, Ruhstaller Thomas, Mayer Gisela, Räss Andrea, Mey Ulrich, von Moos Roger
Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiation
Trepp R, Padberg B, Varga Z, Cathomas R, Inauen R, Reinhart W. Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiation. Pathology, research and practice 2009
17.07.2009Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiation
17.07.2009Pathology, research and practice 2009
Trepp Roman, Padberg Barbara C, Varga Zsuzsanna, Cathomas Richard, Inauen Roman, Reinhart Walter H